Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
ElsMed
Agfa Healthcare

Simulations Demonstrate Neutron-Stimulated Emission CT and Gamma-Stimulated Emission CT to Be Safe

By Medimaging International staff writers
Posted on 16 Jun 2014
Image: Simulated three-dimensional (3D) dose measurements of the breast showing the dose imparted to the whole body. The dose is shown on a red and yellow color map, where yellow shows maximum dose (Photo courtesy of Duke Medicine).
Image: Simulated three-dimensional (3D) dose measurements of the breast showing the dose imparted to the whole body. The dose is shown on a red and yellow color map, where yellow shows maximum dose (Photo courtesy of Duke Medicine).
Image: Simulated 3D dose measurements of the abdomen/liver showing the dose imparted to the whole body. The dose is shown on a red and yellow color map, where yellow shows maximum dose (Photo courtesy of Duke Medicine).
Image: Simulated 3D dose measurements of the abdomen/liver showing the dose imparted to the whole body. The dose is shown on a red and yellow color map, where yellow shows maximum dose (Photo courtesy of Duke Medicine).
Gamma and neutron imaging offer possible enhancements over existing imaging techniques such as X-ray or computed tomography (CT), but their safety has not yet been fully determined. Using computer simulations, imaging the breast and liver with gamma or neutron radiation was found to be safe, delivering levels of radiation comparable with conventional medical imaging, according to researchers.

The findings, published in the June 2014 issue of the journal Medical Physics, will help researchers to move evaluation of gamma and neutron imaging into animals and later humans. Standard medical imaging tools, including X-ray, ultrasound, CT, and magnetic resonance imaging (MRI), identify disease by finding the anatomy, or shape and size, of the abnormality. When applying these applications to screen for cancer, a tumor must be large enough to be detected, and if found, a surgical biopsy is typically needed to determine if it is benign or malignant.

Duke University (Durham, NC, USA) researchers are working to develop imaging technologies to detect disease in its earliest stages, much before the tumors grow large enough to be detected using traditional approaches. Two imaging techniques they are researching are neutron-stimulated emission CT and gamma-stimulated emission CT.

Research has shown that many tumors have an out-of-balance concentration of trace-level elements naturally found in the body, such as rubidium and aluminum. These elements stray from their normal concentration levels at the earliest stages of tumor growth, potentially providing an early indication of disease.

The neutron and gamma imaging modalities measure the concentrations of elements in the body, determining molecular characteristics without the need for a biopsy or injection of contrast media. The goal is for these tests to be able to distinguish between benign and malignant lesions, as well as healthy tissue. “Gamma and neutron imaging may eventually be able to help us to detect cancer earlier without having to perform an invasive biopsy,” said Anuj Kapadia, PhD, assistant professor of radiology at Duke University School of Medicine and the study’s senior author.

Gamma and neutron imaging may also have applications for patients undergoing cancer treatment. Patients currently wait weeks or months to see if their cancer is responding to a particular treatment and shrinking in size, but gamma and neutron imaging may be able to tell if a treatment is working earlier by detecting molecular changes directly within the tumor.

While improved diagnostic tests would provide clinicians with useful tools, one ongoing question is the safety of gamma, and in particular, neutron radiation. Upon entering the body, neutrons scatter considerably, with the possibility of reaching several vital organs. Therefore, researchers have been apprehensive about how much radiation is absorbed in the targeted organ versus surrounding tissue. For instance, in a breast scan, the researchers need to know how much radiation is delivered unnecessarily to the heart or lungs.

Using detailed computer simulations, Dr. Kapadia and his colleagues estimated the radiation dose delivered to the liver and breast using neutron and gamma imaging. They found that the majority of radiation was delivered to organs directly within the radiation beam, and a much lower dose was absorbed by tissue outside of the radiation beam.

In simulated breast scans, the radiation was almost entirely limited to the area of the breast being scanned. The dose to the breast accounted for 96% of the radiation in neutron scans and 99 percent in gamma scans. The heart and lungs received less than 1% of the radiation dose.

When imaging the liver in simulation, the neutron scan imparted the highest radiation dose to the liver, while in the gamma scan, the stomach wall absorbed the greatest amount of radiation because of its location in the direct path of the beam. Further research is needed to decrease and better target gamma radiation doses in liver scans, according to the investigators. “The results show that despite the use of a highly scattering particle such as a neutron, the dose from neutron imaging is on par with other clinical imaging techniques such as X-ray CT,” Dr. Kapadia concluded. “Neutron and gamma radiation may become viable imaging alternatives if further testing proves them to be safe and effective.”

The researchers will use these data to move their studies into animals, and later, human trials.

Related Links:

Duke University



Channels

Radiography

view channel
Image: Changing CT scanners shape in response to patient waistlines. The CT imaging systems of today have up to 300 kg table weight allowance, 2 x 120 kW power, and an 80-cm bore (Photo courtesy of Siemens Healthcare).

Changing the Shape of CT Scanners in Response to Patient’s Expanding Waistlines

As computed tomography (CT) imaging systems continue to grow in size, weight capacity and ability to adapt for the growing waistline of patient population is essential. A recent evaluation, performed... Read more

MRI

view channel
Image: Amyloid plaques showing up in retinal scan as fluorescent spots as curcumin binds to them (Photo courtesy of CSIRO).

Retinal Imaging Detects Changes Associated with Alzheimer's Disease

A noninvasive optical imaging device can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer's disease (AD), according to a new study. Researchers at... Read more

Ultrasound

view channel
Image: The Vivid T8 cardiovascular ultrasound system offers quantitative features such as stress echo and transesophageal echocardiography (TEE) capabilities (Photo courtesy of GE Healthcare).

Mobile, Cardiovascular Ultrasound Features Stress Echo and Transesophageal Echocardiography Capabilities

A 58.5-kg mobile cardiovascular ultrasound system features innovative quantitative features such as stress echo, and transesophageal echocardiography (TEE) capabilities, designed for healthcare providers... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel

IT Technology Unifies Images, Data, and Reporting Workflows Throughout Hospital Enterprise

A new integrated information technology (IT) system will unify images, data, and reporting workflows across all imaging departments in a hospital. The technology will allow hospitals to expand towards the latest, advanced imaging technology platform. Az Groeninge Hospital (Kortrijk, Belgium) has chosen to replace its... Read more

Industry News

view channel

Hosting and Distribution Collaboration Established to Provide Radiation Dose Monitoring

PHS Technologies Group, LLC (Scottsdale, AZ, USA), a unit of PACSHealth, LLC, and a developer of software that monitors patient exposure to ionizing radiation, reported that Dell Healthcare and Life Sciences (Round Rock, TX, USA) will become a marketing, distribution, and hosting partner for its DoseMonitor OnLine software.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.